Zydus Wellness Ltd (ZYDUSWELL) — shareholding pattern, promoter holding, financials and share price
About Zydus Wellness Ltd (ZYDUSWELL)
Zydus Wellness Ltd operates in the Packaged Foods industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as ZYDUSWELL and on the BSE under scrip code 531335. Its ISIN is INE768C01028.
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
Zydus Wellness Limited is a prominent Indian consumer wellness company specializing in health and wellness products. Its portfolio includes well-known brands like Sugar Free, Complan, Everyuth, and Glucon-D.
The company continues to show robust international growth, with significant expansion in Europe through its acquisition of Comfort Click. This strategic acquisition has allowed Zydus to access new wellness markets across Europe.
Listed peers in Packaged Foods: Bikaji Foods International Ltd, The Bombay Burmah Trading Corporation Ltd, Mrs Bectors Food Specialities Ltd, ADF Foods Ltd, Gopal Snacks Ltd, Prataap Snacks Ltd.
Valuation & Returns
10 Jul 2026At ₹592.2 a share on 10 Jul 2026, Zydus Wellness Ltd (ZYDUSWELL) was valued at a price-to-earnings ratio of 95.55x against an industry P/E of 45.12x and a price-to-book of 3.32x on a book value of ₹178.26 per share as of Mar 2025. Solomo computes return on equity of 3.48% and return on capital employed of 5.61% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 95.55x
- Industry P/E
- 45.12x
- P/B
- 3.32x
- EPS (TTM)
- ₹6.2
- Book value / share
- ₹178.26
- ROE
- 3.48%
- ROCE
- 5.61%
- ROA
- 3.06%
- Debt / equity
- 0.03x
- Dividend yield
- 1.01%
- EBITDA margin
- 12.06%
- 52-week range
- ₹357.55 – ₹606.55
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Zydus Wellness Ltd (ZYDUSWELL) reported revenue of ₹3,961 crore, net profit of ₹197 crore and earnings per share of ₹6.2. That compares with revenue of ₹2,709 crore and net profit of ₹347 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹1,485 crore and net profit ₹162 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 2,009 | 2,255 | 2,328 | 2,709 | 3,961 |
| Net profit (₹ cr) | 309 | 310 | 267 | 347 | 197 |
| EPS (₹) | 9.71 | 9.75 | 8.39 | 10.9 | 6.2 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 4.19% | 13.78% | 10.60% | 16.37% |
| Profit growth | -12.64% | - | 34.06% | 29.97% |
| Stock price CAGR | 14% | 6% | 27% | 50% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 69.64% of Zydus Wellness Ltd (ZYDUSWELL) (up 0.01 pp QoQ), foreign institutional investors (FII) hold 3.32% and domestic institutional investors (DII) hold 19.14%. Market capitalisation was ₹18,841 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2002.
Largest disclosed public shareholders in Jun 2026: Parag Parikh Flexi Cap Fund 7.33%, Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund 5.91%, Quant Mutual Fund - Quant Small Cap Fund 4.23%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 69.64% | - | 3.32% | 19.14% | 30.36% |
| Mar 2026 | 69.63% | - | 3.18% | 18.87% | 30.37% |
| Dec 2025 | 69.63% | - | 3.27% | 18.58% | 30.37% |
| Sep 2025 | 69.63% | - | 3.43% | 18.76% | 30.37% |
| Jun 2025 | 69.63% | - | 3.25% | 19.28% | 30.37% |
| Mar 2025 | 69.63% | - | 3.29% | 19.76% | 30.37% |
| Dec 2024 | 69.62% | - | 3.37% | 20.12% | 30.38% |
| Sep 2024 | 69.62% | - | 3.37% | 20.36% | 30.38% |